Best in Biotech 16 Dec 2024 10 biotech companies to watch in 2025 …in 2025. Table of contents Anavex Life Sciences Lead candidate: blarcamesine, for neurodegenerative diseases Anavex submitted marketing authorization application for blarcamesine for treatment of Alzheimer’s Blarcamesine received FDA orphan drug… December 16, 2024 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Apr 2023 6 new vaccines being developed for difficult-to-treat diseases There are several promising new vaccine candidates being developed for complex diseases that historically have been extremely difficult to find treatments and cures for. The development of these new vaccines… April 12, 2023 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 May 2025 Seven lung cancer companies advancing new treatments in 2025 …we take a look at seven lung cancer companies advancing promising candidates. Table of contents Candel Therapeutics Technology: Viral immunotherapies Lead lung cancer candidate: CAN-2409 Recent news: Announced positive survival… May 20, 2025 - 13 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 13 Feb 2025 Seven companies using metabolomics to decode biology …metabolomic datasets, the company identifies novel drug targets and therapeutic candidates. SB-0110 is the company’s lead candidate, a first-in-class small molecule targeting Parkinson’s disease and levodopa-induced dyskinesia (LID). SB-0110 has… February 13, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 7 Dec 2016 Ask the Biotech Recruiter: Here are 7 Signs it’s Time to Talk to the Headhunters …milestones set in your business plan? Looking to hire a providential candidate for your developments? Recruitment might sound straightforward — find a candidate and make them an offer, right? In… December 7, 2016 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 5 Dec 2022 Positive antibody persistence for vaccine treating mosquito disease …anticipated long-term durability of the antibody response after a single vaccination. Dedicated antibody persistence The antibody persistence trial enrolled 363 healthy adult participants and followed them from month six after… December 5, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 29 Aug 2022 Sanyou and KangaBio to collaborate on antibody drug development and innovation …more than 40 core innovation technology platforms, including platforms for innovative antibody drug discovery with a series of trillion-level phage display antibody libraries, antibody drug optimization, cell line construction, upstream… August 29, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jul 2019 Update: Swiss Biotech’s Series E Expanded to €271M to Commercialize Antibody-Guided Cancer Chemotherapy …blood cancer. With its big Series E complete, the company is in a good financial position to prepare for the commercialization of its lead candidate antibody-drug conjugate treatment, which is… July 9, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 28 May 2025 Myasthenia gravis treatments: what’s on the horizon? …are AChR- positive compared to a 4.7-point recovery in the lower dose arm. Although batoclimab was Immunovant’s long-standing candidate until last year, it switched focus to gear its anti-FcRn antibody… May 28, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 1 Dec 2023 Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered …include its lead asset CBS004, a monoclonal antibody for the treatment of autoimmune conditions. As part of the agreement, CBS004 will be renamed to ANB101 next year. The candidate is… December 1, 2023 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Oct 2024 GPCR therapies: Eight promising biotechs hacking the cell signaling pathway …B funding round to push its preclinical candidates to the clinic. And making a name for itself in the metabolic disease therapeutics space, Confo has discovered antibody-based GPCR agonists that… October 29, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jan 2025 Top biotech deals of December 2024 …and development (R&D) plans. Biotech deals by approach in December 2024 Biotechs continue antibody-drug conjugates R&D streak As usual, licensing deals for antibody-drug conjugates make the cut. American pharma Gilead… January 16, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email